vs

Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $221.4M, roughly 1.7× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 0.2% vs -19.6%, a 19.8% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (6.7% vs 3.8%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (11.7% CAGR vs -0.5%).

P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

PIII vs UTI — Head-to-Head

Bigger by revenue
PIII
PIII
1.7× larger
PIII
$384.8M
$221.4M
UTI
Growing faster (revenue YoY)
UTI
UTI
+2.9% gap
UTI
6.7%
3.8%
PIII
Higher net margin
UTI
UTI
19.8% more per $
UTI
0.2%
-19.6%
PIII
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
11.7%
-0.5%
PIII

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
PIII
PIII
UTI
UTI
Revenue
$384.8M
$221.4M
Net Profit
$-75.5M
$433.0K
Gross Margin
Operating Margin
-40.0%
0.2%
Net Margin
-19.6%
0.2%
Revenue YoY
3.8%
6.7%
Net Profit YoY
-28.8%
-60.5%
EPS (diluted)
$-23.08
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PIII
PIII
UTI
UTI
Q1 26
$221.4M
Q4 25
$384.8M
$220.8M
Q3 25
$345.3M
$222.4M
Q2 25
$355.8M
$204.3M
Q1 25
$373.2M
$207.4M
Q4 24
$370.7M
$201.4M
Q3 24
$362.1M
$196.4M
Q2 24
$379.2M
$177.5M
Net Profit
PIII
PIII
UTI
UTI
Q1 26
$433.0K
Q4 25
$-75.5M
$12.8M
Q3 25
$-31.6M
$18.8M
Q2 25
$-20.4M
$10.7M
Q1 25
$-20.5M
$11.4M
Q4 24
$-58.6M
$22.2M
Q3 24
$-46.5M
$18.8M
Q2 24
$-12.0M
$5.0M
Operating Margin
PIII
PIII
UTI
UTI
Q1 26
0.2%
Q4 25
-40.0%
7.1%
Q3 25
-12.8%
11.2%
Q2 25
-9.6%
6.9%
Q1 25
-10.2%
8.1%
Q4 24
-37.4%
13.6%
Q3 24
-29.5%
13.3%
Q2 24
-8.3%
4.2%
Net Margin
PIII
PIII
UTI
UTI
Q1 26
0.2%
Q4 25
-19.6%
5.8%
Q3 25
-9.1%
8.4%
Q2 25
-5.7%
5.2%
Q1 25
-5.5%
5.5%
Q4 24
-15.8%
11.0%
Q3 24
-12.8%
9.6%
Q2 24
-3.2%
2.8%
EPS (diluted)
PIII
PIII
UTI
UTI
Q1 26
$0.01
Q4 25
$-23.08
$0.23
Q3 25
$-9.67
$0.33
Q2 25
$-6.23
$0.19
Q1 25
$-6.28
$0.21
Q4 24
$-23.13
$0.40
Q3 24
$-15.70
$0.35
Q2 24
$-7.37
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PIII
PIII
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$25.0M
$162.0M
Total DebtLower is stronger
$228.4M
$127.8M
Stockholders' EquityBook value
$-155.2M
$339.9M
Total Assets
$656.6M
$852.2M
Debt / EquityLower = less leverage
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PIII
PIII
UTI
UTI
Q1 26
$162.0M
Q4 25
$25.0M
$162.8M
Q3 25
$37.7M
$169.1M
Q2 25
$38.6M
$70.7M
Q1 25
$40.1M
$96.0M
Q4 24
$38.8M
$172.0M
Q3 24
$63.0M
$161.9M
Q2 24
$73.1M
$115.5M
Total Debt
PIII
PIII
UTI
UTI
Q1 26
$127.8M
Q4 25
$228.4M
$101.4M
Q3 25
$252.8M
$87.1M
Q2 25
$182.0M
$73.8M
Q1 25
$171.1M
$94.4M
Q4 24
$108.9M
$120.1M
Q3 24
$133.2M
$125.7M
Q2 24
$133.1M
$137.3M
Stockholders' Equity
PIII
PIII
UTI
UTI
Q1 26
$339.9M
Q4 25
$-155.2M
$335.9M
Q3 25
$-18.7M
$328.1M
Q2 25
$44.5M
$306.8M
Q1 25
$63.3M
$293.9M
Q4 24
$75.9M
$280.0M
Q3 24
$120.5M
$260.2M
Q2 24
$166.8M
$239.4M
Total Assets
PIII
PIII
UTI
UTI
Q1 26
$852.2M
Q4 25
$656.6M
$834.0M
Q3 25
$683.6M
$826.1M
Q2 25
$731.6M
$740.8M
Q1 25
$783.9M
$720.4M
Q4 24
$783.4M
$753.8M
Q3 24
$833.3M
$744.6M
Q2 24
$892.8M
$706.0M
Debt / Equity
PIII
PIII
UTI
UTI
Q1 26
0.38×
Q4 25
0.30×
Q3 25
0.27×
Q2 25
4.09×
0.24×
Q1 25
2.71×
0.32×
Q4 24
1.43×
0.43×
Q3 24
1.11×
0.48×
Q2 24
0.80×
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PIII
PIII
UTI
UTI
Operating Cash FlowLast quarter
$-25.7M
$7.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
16.33×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PIII
PIII
UTI
UTI
Q1 26
$7.1M
Q4 25
$-25.7M
$3.1M
Q3 25
$-15.4M
$57.1M
Q2 25
$-16.6M
$18.1M
Q1 25
$-33.5M
$-789.0K
Q4 24
$-57.2M
$23.0M
Q3 24
$-22.6M
$67.5M
Q2 24
$-10.2M
$10.0M
Free Cash Flow
PIII
PIII
UTI
UTI
Q1 26
Q4 25
$-19.2M
Q3 25
$40.6M
Q2 25
$6.8M
Q1 25
$-11.7M
Q4 24
$19.6M
Q3 24
$60.0M
Q2 24
$3.0M
FCF Margin
PIII
PIII
UTI
UTI
Q1 26
Q4 25
-8.7%
Q3 25
18.3%
Q2 25
3.4%
Q1 25
-5.7%
Q4 24
9.7%
Q3 24
30.6%
Q2 24
1.7%
Capex Intensity
PIII
PIII
UTI
UTI
Q1 26
Q4 25
10.1%
Q3 25
7.4%
Q2 25
5.5%
Q1 25
5.3%
Q4 24
0.0%
1.7%
Q3 24
0.0%
3.8%
Q2 24
0.0%
4.0%
Cash Conversion
PIII
PIII
UTI
UTI
Q1 26
16.33×
Q4 25
0.24×
Q3 25
3.04×
Q2 25
1.69×
Q1 25
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PIII
PIII

Capitated Revenue$366.2M95%
Health Care Patient Service$18.6M5%
Health Care Care Coordination Management Fees$2.7M1%

UTI
UTI

Segment breakdown not available.

Related Comparisons